| WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8. | WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.
Zhou L, Zhong Y, Wang F, Guo Y, Mao R, Xie H, Zhang Y, Li J., Free PMC Article | 03/15/2024 |
| Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells. | Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells.
Li F, Qiu F, Fan X, Yu Q, Liu S, Guo Y, Zhu Y, Xi X, Du B. | 11/3/2023 |
| ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer. | ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L, Wang H, Guo M, He M, Zhang W, Zhan M, Liu Y. | 07/21/2023 |
| An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. | An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.
Horie M, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E, Miyashita N, Saito A, Nakatani Y, Yachida S., Free PMC Article | 06/5/2023 |
| ESE1/AGR2 axis antagonizes TGF-beta-induced epithelial-mesenchymal transition in low-grade pancreatic cancer. | ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer.
Xu HJ, Bai J, Tian Y, Feng X, Chen AP, Wang J, Wu J, Jin XR, Zhang F, Quan MY, Chen C, Lee KY, Zhang JS., Free PMC Article | 03/24/2023 |
| MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells. | MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.
Shchuka VM, Khader N, Dorogin A, Shynlova O, Mitchell JA., Free PMC Article | 01/11/2023 |
| LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. | LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex.
Li D, Shen L, Zhang X, Chen Z, Huang P, Huang C, Qin S., Free PMC Article | 12/10/2022 |
| Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. | Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R.
Seo SH, Hwang SY, Hwang S, Han S, Park H, Lee YS, Rho SB, Kwon Y., Free PMC Article | 08/13/2022 |
| Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma. | Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.
Dong Z, Yang L, Lu J, Guo Y, Shen S, Liang J, Guo W. | 08/6/2022 |
| ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate. | ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.
Archer LK, Frame FM, Walker HF, Droop AP, McDonald GLK, Kucko S, Berney DM, Mann VM, Simms MS, Maitland NJ., Free PMC Article | 07/16/2022 |
| ELF3 mediates IL-1alpha induced differentiation of mesenchymal stem cells to inflammatory iCAFs. | ELF3 mediates IL-1α induced differentiation of mesenchymal stem cells to inflammatory iCAFs.
Tran LL, Dang T, Thomas R, Rowley DR., Free PMC Article | 05/7/2022 |
| WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma. | WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma.
Na L, Wang Z, Bai Y, Sun Y, Dong D, Wang W, Zhao C. | 01/1/2022 |
| FZD5 prevents epithelial-mesenchymal transition in gastric cancer. | FZD5 prevents epithelial-mesenchymal transition in gastric cancer.
Dong D, Na L, Zhou K, Wang Z, Sun Y, Zheng Q, Gao J, Zhao C, Wang W., Free PMC Article | 01/1/2022 |
| ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCiota. | ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.
Lee JS, Choi YE, Kim S, Han JY, Goh SH., Free PMC Article | 12/25/2021 |
| Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies. | Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies.
Boti MA, Adamopoulos PG, Tsiakanikas P, Scorilas A., Free PMC Article | 12/18/2021 |
| Inhibition of ELF3 confers synthetic lethality of PARP inhibitor in non-small cell lung cancer. | Inhibition of ELF3 confers synthetic lethality of PARP inhibitor in non-small cell lung cancer.
Wang Y, Zuo M, Jin H, Lai M, Luo J, Cheng Z. | 11/13/2021 |
| Vorinostat ameliorates IL-1alpha-induced reduction of type II collagen by inhibiting the expression of ELF3 in chondrocytes. | Vorinostat ameliorates IL-1α-induced reduction of type II collagen by inhibiting the expression of ELF3 in chondrocytes.
Miao X, Wu Y, Wang P, Zhang Q, Zhou C, Yu X, Cao L., Free PMC Article | 10/2/2021 |
| Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells. | Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
Park SW, Do HJ, Choi W, Lim DS, Park KH, Kim JH. | 08/7/2021 |
| ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts. | ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts.
Li Q, Meissner TB, Wang F, Du Z, Ma S, Kshirsagar S, Tilburgs T, Buenrostro JD, Uesugi M, Strominger JL., Free PMC Article | 08/7/2021 |
| ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer. | ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer.
Takaoka A, Ishikawa T, Okazaki S, Watanabe S, Miya F, Tsunoda T, Kikuchi A, Yamauchi S, Matsuyama T, Tokunaga M, Uetake H, Kinugasa Y., Free PMC Article | 07/31/2021 |
| A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma. | A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.
Ma S, Zhou B, Yang Q, Pan Y, Yang W, Freedland SJ, Ding LW, Freeman MR, Breunig JJ, Bhowmick NA, Pan J, Koeffler HP, Lin DC., Free PMC Article | 05/22/2021 |
| E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer. | E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
Suzuki M, Saito-Adachi M, Arai Y, Fujiwara Y, Takai E, Shibata S, Seki M, Rokutan H, Maeda D, Horie M, Suzuki Y, Shibata T, Kiyono T, Yachida S. | 05/8/2021 |
| High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. | High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression.
Wang J, Shen X, Liu J, Chen W, Wu F, Wu W, Meng Z, Zhu M, Miao C., Free PMC Article | 04/13/2021 |
| ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR(+)HER2(+) breast cancer patients. | ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR(+)HER2(+) breast cancer patients.
Kar A, Koto K, Walker D, Trudeau T, Edgerton S, Thor A, Gutierrez-Hartmann A. | 02/6/2021 |
| Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. | Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Pandey A, Stawiski EW, Durinck S, Gowda H, Goldstein LD, Barbhuiya MA, Schröder MS, Sreenivasamurthy SK, Kim SW, Phalke S, Suryamohan K, Lee K, Chakraborty P, Kode V, Shi X, Chatterjee A, Datta K, Khan AA, Subbannayya T, Wang J, Chaudhuri S, Gupta S, Shrivastav BR, Jaiswal BS, Poojary SS, Bhunia S, Garcia P, Bizama C, Rosa L, Kwon W, Kim H, Han Y, Yadav TD, Ramprasad VL, Chaudhuri A, Modrusan Z, Roa JC, Tiwari PK, Jang JY, Seshagiri S., Free PMC Article | 09/19/2020 |